Abstract
Twenty-seven years of WHO/TDR experience with public–private partnerships
MeSH terms
-
Humans
-
Ivermectin / therapeutic use
-
Onchocerciasis / drug therapy
-
Orphan Drug Production*
-
Rare Diseases / drug therapy*
-
Rare Diseases / economics
-
Rare Diseases / prevention & control*
-
Research / trends*
-
Research Support as Topic
-
Voluntary Health Agencies*
-
World Health Organization